Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Amasten on its offer for SSM
Mandate

Vinge advises Amasten on its offer for SSM

October 16, 2020 Capital Markets and Public M&A EU, Competition and Regulatory Banking and Finance Real Estate and Construction Corporate Tax

Vinge advises Amasten Fastighets AB (publ) in connection with its public offer to the shareholders of SSM Holding AB (publ) (“SSM”)

The offer consideration consists of shares in Amasten, corresponding to a value of approximately SEK 400 million. Amasten is a property company that manages, develops and builds. The property portfolio consists of 92 percent housing, whereby the remaining area consists of office, retail, industrial and community premises. SSM produces smart, affordable homes with attractive shared spaces close to public transport and the city centre for its target group – tomorrow’s urbanites.

Vinge’s team consists of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm, Boris Kotur, Clara Sohlberg, Lisa Malmborg and Emil Lindwall (Capital Markets and Public M&A), Johan Wahlbom and Joel Kokko (EU, Competition and Regulatory), Pauline Lagerstrand and Felix Möller (Banking and Finance), Henrik Wastenson (Corporate Tax) as well as Kristofer Larson (Real Estate).


Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025